ENZON PHARMACEUTICALS INC
ENZN
ENZN was delisted on the 19th of May, 2016.
83 hedge funds and large institutions have $70.2M invested in ENZON PHARMACEUTICALS INC in 2013 Q2 according to their latest regulatory filings, with 83 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
90% less call options, than puts
Call options by funds: $2K | Put options by funds: $20K
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WJA
76
Williams Jones & Associates
New York
| $20K | +$29.3K | +10,000 | New |
|
77
Ameriprise
Minneapolis,
Minnesota
| $15K | +$22.2K | +7,569 | New |
|
78
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $8K | +$11.6K | +3,948 | New |
|
79
BlackRock
New York
| $2K | +$2.39K | +815 | New |
|
|
KTC
80
Kistler-Tiffany Companies
Berwyn,
Pennsylvania
| $2K | +$2.42K | +825 | New |
|
81
Creative Planning
Overland Park,
Kansas
| $1K | +$878 | +300 | New |
|
82
Group One Trading
Chicago,
Illinois
| $1K | +$1.64K | +561 | New |
|
|
WT
83
Whittier Trust
South Pasadena,
California
| $1K | +$1.98K | +675 | New |
|
ENZN Hedge Fund Activity: Q2 2013 in Review
83 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in ENZON PHARMACEUTICALS INC (ENZN) for Q2 2013, worth a combined $70.2M.
Buyers outnumbered sellers: 83 funds opened new ENZN positions and 0 closed out — a net gain of 83 holders — while 0 added to existing stakes and 0 trimmed.
- 83 institutional investors held ENZON PHARMACEUTICALS INC (ENZN) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $70.2M of ENZON PHARMACEUTICALS INC stock for Q2 2013.
- 83 funds opened new ENZON PHARMACEUTICALS INC positions in Q2 2013 and 0 closed out, a net change of +83 holders.
Based on aggregated 13F filings for Q2 2013.